Shixian Hua
Jiangsu Province Hi Tech Key Laboratory For Biomedical Research
Nanjing, 211189, China
Nanjing, 211189, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
The introduction of immunosuppressor (TDO inhibitor) significantly improved the efficacy of irinotecan in treating hepatocellular carcinoma.
Journal: Cancer immunology, immunotherapy : CII
Published: June 16, 2020
Microtubule inhibitors containing immunostimulatory agents promote cancer immunochemotherapy by inhibiting tubulin polymerization and tryptophan-2,3-dioxygenase.
Journal: European journal of medicinal chemistry
Published: October 16, 2019
Dual-functional conjugates improving cancer immunochemotherapy by inhibiting tubulin polymerization and indoleamine-2,3-dioxygenase.
Journal: European journal of medicinal chemistry
Published: September 26, 2019
Novel conjugates with dual suppression of glutathione S-transferases and tryptophan-2,3-dioxygenase activities for improving hepatocellular carcinoma therapy.
Journal: Bioorganic chemistry
Published: February 07, 2019
Multifunctional platinum(IV) complexes as immunostimulatory agents to promote cancer immunochemotherapy by inhibiting tryptophan-2,3-dioxygenase.
Journal: European journal of medicinal chemistry
Published: January 07, 2019
Pt(IV) hybrids containing a TDO inhibitor serve as potential anticancer immunomodulators.
Journal: Journal of inorganic biochemistry
Published: September 09, 2018
Glycyrrhetinic acid derivatives containing aminophosphonate ester species as multidrug resistance reversers that block the NF-κB pathway and cell proliferation.
Journal: Bioorganic & medicinal chemistry letters
Published: June 27, 2018
Dual-targeting antitumor hybrids derived from Pt(IV) species and millepachine analogues.
Journal: European journal of medicinal chemistry
Published: November 28, 2017
Showing 1-8 of 8
Last Updated: 09/26/2026